Biophysicist obtains first experimental evidence of pressure inside the herpes virus

July 24, 2013
Carnegie Mellon biophysicist obtains first experimental evidence of pressure inside the herpes virus
This is an electron micrograph of herpes simplex virus type 1 infecting a cell. Carnegie Mellon researchers have for the first time calculated the pressure inside the virus that powers the ejection of viral DNA into a host cell. Credit: Carnegie Mellon University

Herpes viruses are like tiny powder kegs waiting to explode. For more than 20 years scientists suspected that herpes viruses were packaged so full of genetic material that they built up an internal pressure so strong it could shoot viral DNA into a host cell during infection. No one had been able to prove that theory until now.

Carnegie Mellon University biophysicist Alex Evilevitch together with his graduate student David Bauer and University of Pittsburgh collaborators Fred Homa and Jamie Huffman have measured, for the first time, the pressure inside human 1 (HSV-1). The study, published online in the Journal of the American Chemical Society, provides the first experimental evidence of high internal pressure within a virus that infects humans. This phenomenon was previously only attributed to that infect bacteria, called bacteriophages.

"Despite billions of years of evolution separating eukaryotic viruses and bacteriophages, the existence of an internal pressure capable of powering the ejection of DNA into a host cell has been conserved. This suggests that it is a key mechanism for viral infection across organisms and presents us with a new for ," said Evilevitch, associate professor of physics.

Current are highly specialized. They target molecules essential to the replication cycle of specific viruses, so each medication is designed to treat only one type of viral infection. Additionally, since viruses mutate over time, they can become less susceptible to targeted medications. But designing drugs aimed at stopping a fundamental mechanism of viral infection, in this case the tightly packed genome that causes such high internal pressure, could yield new classes of broad-based, mutation-resistant antiviral treatments, according to Evilevitch.

Many viruses, whether they infect bacteria, plants or animals, are adept at packing long stretches of nucleic acid (DNA or RNA) within their nanometer-sized protein shells. HSV-1 contains double-stranded DNA that is 400 times longer than the radius of the viral shell it fills. The DNA gets packaged so tightly that it bends upon itself, resulting in repulsive forces that exert tremendous energy and pressure on the virus's outer shell. When HSV-1 infects a cell, it enters through the outer cell membrane and makes its way to the cell nucleus, where it docks in a small hole found in the nuclear membrane. That act is like a key opening a lock that allows the HSV-1 to eject its DNA into the cell nucleus.

For years scientists hypothesized that a high internal pressure inside eukaryotic viruses like HSV-1 enabled the virus to shoot its DNA into the 's nucleus. But it was impossible to measure HSV-1's internal pressure without knowing how to release the viral DNA in a controlled, experimental setting. Evilevitch's colleagues William Newcomb and Jay Brown, professors of microbiology and cancer biology at the University of Virginia's School of Medicine, discovered protein called UL6 that, when degraded, caused DNA to exit the virus. In his experiment, Evilevitch and Bauer degraded UL6, which triggered HSV-1 to eject its DNA. At the same time, they applied an external force to the virus and monitored how much DNA was released. When the external pressure reached tens of atmospheres, HSV-1 didn't release any DNA, indicating that the internal and external pressure were equal.

"This measurement of high internal pressure - tens of atmospheres - within a human virus is a fundamentally important discovery of the physical-chemical mechanism of eukaryotic viral infection," Evilevitch said.

The mechanism of pressurized infection found in HSV-1 is applicable to any of the eight known Herpes viruses that cause disease in humans, including Varicella zoster virus, which causes chickenpox in children and shingles in adults, and the Epstein-Barr virus, which causes mononucleosis and is associated with several types of cancer, such as Hodgkin's lymphoma.

Explore further: Herpes research turns up genetic combatant

More information: pubs.acs.org/doi/abs/10.1021/ja404008r

Related Stories

Herpes research turns up genetic combatant

July 18, 2013
(Medical Xpress)—A molecule that could potentially be used to fight herpes simplex virus (HSV-1) has been discovered by Curtin University scientists.

Study reveals new approach for stopping herpes infections

March 25, 2013
Researchers at Albert Einstein College of Medicine of Yeshiva University have discovered a novel strategy for preventing infections due to the highly common herpes simplex viruses, the microbes responsible for causing genital ...

Herpes virus exploits immune response to bolster infection

June 6, 2013
Researchers at the University of California, San Diego School of Medicine and colleagues report that the herpes simplex virus type-1 (HSV-1), which affects an estimated 50 to 80 percent of all American adults, exploits an ...

Hidden strains of HPV found in 'virus-negative' genital warts

July 11, 2013
There are 170 established HPV types. Cancerous human papillomavirus (HPV) viruses are the main cause of cervical cancer, and are found in close to 100% of cervical tumors.

Recommended for you

Team finds link between backup immune defense, mutation seen in Crohn's disease

July 27, 2017
Genes that regulate a cellular recycling system called autophagy are commonly mutated in Crohn's disease patients, though the link between biological housekeeping and inflammatory bowel disease remained a mystery. Now, researchers ...

Study finds harmful protein on acid triggers a life-threatening disease

July 27, 2017
Using an array of modern biochemical and structural biology techniques, researchers from Boston University School of Medicine (BUSM) have begun to unravel the mystery of how acidity influences a small protein called serum ...

CRISPR sheds light on rare pediatric bone marrow failure syndrome

July 27, 2017
Using the gene editing technology CRISPR, scientists have shed light on a rare, sometimes fatal syndrome that causes children to gradually lose the ability to manufacture vital blood cells.

Post-stroke patients reach terra firma with new exosuit technology

July 26, 2017
Upright walking on two legs is a defining trait in humans, enabling them to move very efficiently throughout their environment. This can all change in the blink of an eye when a stroke occurs. In about 80% of patients post-stroke, ...

Molecular hitchhiker on human protein signals tumors to self-destruct

July 24, 2017
Powerful molecules can hitch rides on a plentiful human protein and signal tumors to self-destruct, a team of Vanderbilt University engineers found.

Researchers develop new method to generate human antibodies

July 24, 2017
An international team of scientists has developed a method to rapidly produce specific human antibodies in the laboratory. The technique, which will be described in a paper to be published July 24 in The Journal of Experimental ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

HollyIves
1 / 5 (1) Jul 24, 2013
'Herpes Infections - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Herpes Infections, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Herpes Infections.
Just check out HerpesLTR.com to find your Long Term Relationship & Support!

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.